key: cord-0838233-h6xa91pu
authors: Baildya, Nabajyoti; Khan, Abdul Ashik; Ghosh, Narendra Nath; Dutta, Tanmoy; Chattopadhyay, Asoke P.
title: Screening of potential drug from Azadiractha Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies
date: 2020-10-03
journal: J Mol Struct
DOI: 10.1016/j.molstruc.2020.129390
sha: 02a2e8cc0ca9b54fe004eabd219ecc80f66f215d
doc_id: 838233
cord_uid: h6xa91pu

Azadirachta Indica (Neem) extracts have been known for their anti-bacterial and other effects since ancient times. The present work examines the inhibitory activity of Neem extracts on Papain like protease (PLpro) of the novel coronavirus SARS-CoV-2. The activity is analysed by molecular docking study along with molecular dynamics simulation. All the studied Neem compounds showed decent level of inhibitory activities against PLpro of SARS-CoV-2. Among them, desacetylgedunin (DCG) found in Neem seed showed the highest binding affinity towards PLpro. Furthermore, MD-simulation studies supported by standard analysis (e.g. root mean square deviation and fluctuation (RMSD, RMSF), radius of gyration, solvent accessible surface area (SASA)) showed large impact on the structure of PLpro by DCG. We believe that the significant effect of DCG on PLpro may help in therapeutic efforts against SARS-CoV-2.

Recent pandemic caused by the novel coronavirus SARS-CoV-2 (COVID-19 in short) has thrown a big challenge to humanity. COVID-19 belongs to the beta-coronavirus group, very similar to previously reported SARS coronavirus [1] . Supposedly originating from bats and pangolins [2] , it spreads very rapidly through human to human community transmission [3] .

It is a fairly large virus, with spike glycoproteins on outer surface, a membrane, envelope, and nucleocapsid protein containing a positive sense single strand of RNA, which consists, among others, of a 5'-untranslated region (UTR), a replicase complex (ORF1ab) encoding non-structural proteins (nsps) [4] . It is now known that the virus enters into host cell by the interaction of spike protein to the angiotensin-converting enzyme-2 (ACE-2) receptors in host cell and uses the cellular serine protease TMPRSS2 for S protein priming. It also encodes cysteine protease, a serine protease, besides the main protease (3CLpro) and a papain-like protease (PLpro). These may participate in cleavage of viral polyproteins [5, 6] , leading to creation of active substances for replication of virus inside the host cell. Therefore, activity of each of these individual entities and binding of the virus to the host cell, and activity of ACE-2 have all been examined in finding potential antidote to COVID-19.

However, despite much effort, there is no potentially active drug or vaccine available till date which can effectively combat SARS-CoV-2. Although several drugs (chloroquine, hydroxychloroquine, remdesivir etc.) are recommended against COVID-19, many adverse effects of these have also been reported [7, 8] . These drug molecules target different entities in the virus or its binding with the host cell. It was decided to focus on activity of the papain-like protease PLpro and how to inhibit it in the present work.

The present work is to find out potential drugs against COVID-19 from natural sources such as the medicinal plant Neem, (Azadirachta Indica). There have been a lot of investigations on Neem extracts from its leaves, fruits, bark etc. It is known that compounds in Neem extracts have anti-inflammatory, anti-hyperglycaemic, anti-carcinogenic, immune-modulator, antimutagenic, anti-oxidant, anti-ulcer and anti-viral effects [9] . Anti-viral effects of Neem extracts include inhibitory action against herpes, [10] smallpox, chickenpox [11, 12] and even HIV [13] . Compounds in Neem extract are also active against polio virus, coxackie B group virus, HIV and dengue virus at early step of viral genome replication [12] [13] [14] [15] [16] [17] . In the present work we have selected 19 natural compounds of Neem and evaluated their inhibitory potency against PLpro of SAS-COV-2 through molecular docking and molecular dynamics simulation.

The crystal structure of papain like protease (PLpro) of SARS-COV-2 (PDB ID: 6W9C) [18] was obtained from the Protein Data Bank. Only chain-A of PLpro was chosen for docking studies. Structures of 7 drugs in use against COVID-19, and 19 compounds from NEEM extacts, were obtained from the PubChem (National Library of Medicine) and were converted to check the ligand-protein binding interaction using UCSF Chimera [19] . The structure of PLpro was prepared by eliminating hetero-atoms and chain B and C using UCSF Chimera package. Autodock Vina [20] was used to obtained the best docking configuration between PLpro and the drug molecules. Autodock Tools was used to prepare necessary files for docking simulation.

Molecular dynamics (MD) simulation studies were performed using GROMACS (Version 2018.5) [21] with the minimum energy configurations obtained from docking studies using the CHARMM36-mar2019 force-field [22] by TIP3P model [23] . The topology and the parameter files were generated for the ligand desacetylgedunin (DCG) (the compound with highest docking with PLpro) from CHARMM General Force Field server. To maintain periodic boundary conditions a cubical box was generated. The PLpro-DCG complex was at least 1 nm from the edges of the box to maintain at least 2 nm distance between two successive images of the complex. Three Clions were added to neutralize the system.

Energy minimization was carried out until the maximum force becomes less than 10 kJmol -1 nm -1 . The steepest descent algorithm was used followed by conjugate gradient protocol.

Then isochoric-isothermal (NVT) ensemble was used for the equilibration of the system for 1000 ps at 300 K. 2 fs time step was taken. Isothermal-isobaric or NPT ensemble is then used for equilibration at 300 K for 1000 ps. For the NPT ensemble modified Berendsen thermostat was used. Time step was kept 2 fs. The electrostatic and van der Waals interaction cut off were kept at 1.0 nm for both NVT and NPT equilibration. Long range interactions were calculated using smooth particle mesh Ewald (PME) method [24] . With same electrostatic and van der Waals cut off, the equilibrated ensembles were finally subjected to MD simulation for 100 ns. PME method was used to calculate long range electrostatic interactions. A modified Berendsen thermostat and a Parinello-Rahman barostat were used with reference temperature and pressure at 300K and 1 bar respectively. Snapshots of the trajectory were saved after every nanosecond.

The structural trajectories for PLpro-DCG systems were calculated using trjconv tool. To recentre the protein and other molecules within the cubical box, the same tool was used. gmx energy tool was used to calculate the van der Waals interaction, conformational energy etc.

xmgrace tool was used to plot RMSD, RMSF, Radius of gyration and solvent accessible surface area (SASA) plots.

19 major compounds found in different parts of Neem are chosen to analyse their potential inhibitory capacity against PLpro of corona virus. Table 1 lists the binding affinities of these compounds along with their molecular formula and structure. The highest binding affinity was obtained as -7.3Kcal/mol for desacetylgedunin (DCG) against PLpro. Table 2 shows the binding affinities of some well known potentially active drugs against PLpro. It is clear from the Table 1 and 2 that the desacetylgedunin showed higher binding affinity than all the known and active drugs used. Furthermore to predict the toxicity level of the studied compounds, we have performed standard absorption-distribution-metabolism-excretion (ADME) toxicity analysis by pkCSM online server [25] .

Prediction of ADME-Evaluation of pharmacokinetic properties of the studied compounds suggests that they are effectively absorbed by the gastro-intestinal part with low blood-brainbarrier (BBB) permeability value and these drugs do not affect CYP2D6, CYP2C9 and CYP2D6 cytochromes. Skin permeability for these compounds is found to be between -2.314

to -3.599 units. The toxicity table is shown in Table S1 . Table 3 .

From the above analysis it is clear that the studied compounds of Neem extract showed low toxicity level compared to standard anti-COVID-19 drugs. From the binding affinity and toxicity level analysis we have selected DCG for further analysis. Fig. 1 represents docked cavities of Neem compounds against PLpro with high binding affinity. Table 1 it is clear that DCG has the highest docking score so the binding sites and the 2D-contour plot of DCG against PLpro are shown in Fig. 2 . Fig. 3 . After 40 ns, the RMSD fluctuation of PLpro-DCG becomes much more prominent indicating huge conformational and structural changes of the docked structure. We note that the fluctuation is maximized at 100 ns which is reflected from the structural changes as discussed Fig. 6 . Post MD-simulation docking analysis with PLpro, captured for each 10 ns was also performed to understand the binding affinity of DCG against PLpro during MD trajectory which is shown in Table 4 . During MD-simulation the binding affinity ranges from -7.2 to -6.4 Kcal/mol. This clearly shows the prominent effect of the drug within the PLpro cavity. 

The authors declare no conflicting interest in the present work.

Data is available upon request to the corresponding author. Table 3 : Toxicity prediction of compounds of Neem extracts along with some standard anti-COVID-19 drugs Table 4 : Docking score analysis during MD-simulation between DCG and PLpro after each 10ns period 

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

SARS-CoV-2: an emerging coronavirus that causes a global threat

of the International, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Mechanisms of coronavirus cell entry mediated by the viral spike protein

The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds

Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

Medicinal properties of neem leaves: a review

In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection

Azadirachta indica): Prehistory to contemporary medicinal uses to humankind

Neem: a tree for solving global problems

An antimalarial extract from neem leaves is antiretroviral

Screening and design of anti-diabetic compounds sourced from the leaves of neem (Azadirachta indica)

Antihyperglycemic activity of compounds isolated from Indian medicinal plants

Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat

Accacia nilotica phytochemicals against HCV NS3/4a

The crystal structure of papain-like protease of SARS CoV-2, RSCB PDB

UCSF Chimera-a visualization system for exploratory research and analysis

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

GROMACS: a message-passing parallel molecular dynamics implementation

CHARMM TIP3P water model suppresses peptide folding by solvating the unfolded state

Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4

pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures

The authors wish to acknowledge infrastural support from Department of Chemistry, University of Kalyani, Kalyani, Nadia, India.

Nabajyoti Baildya: Conceptualization, planning, execution, writing Abdul Ashik Khan: Planning, execution, writing Narendra Nath Ghosh: Conceptualization, planning, execution, writing Tanmoy Dutta: Planning, execution, writing Asoke P. Chattopadhyay: Planning, supervision, writing

☐The authors declare that they have no known competing financialinterestsor personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: